We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

CAR T Cell Therapy Shows Promise in Acute Myeloid Leukemia

News   May 10, 2018 | Original story from Moffitt Cancer Centre

 
CAR T Cell Therapy Shows Promise in Acute Myeloid Leukemia

Relapsed AML patient treated with CYAD-01 CAR-T therapy. CD34 IHC of the core biopsy shows clusters of blasts (~7%) consistent with relapsed disease (Panel A). Prominent dysmegakaryopoiesis was also noted (Panel B). BM biopsy at day +56 following 3 infusions of CYAD-01 showed normal trilineage hematopoiesis with CD34 IHC showing no increase in blasts (Panel C). Patient also with significant improvement of hematopoiesis as transfusion independent with marked increase of hemoglobin and platelet count (Panel D). Credit: doi:10.3324/haematol.2017.186742

 
 
 

RELATED ARTICLES

Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

News

Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines.

READ MORE

Drug Blocks Pancreatic Cancer Growth in Mice

News

A newly developed drug can prevent the most common type of pancreatic cancer from growing and spreading in laboratory mice, according to a new study.

READ MORE

Rare and Undiagnosed Conditions Get Massive Research Funding Boost

News

Five new clinical sites, a new metabolomics core, and increased model organism capabilities among additions.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE